Owner PROTEINEXPRESS CO., LTD. TAKEMORI, Hiroshi OKAMOTO, Mitsuhiro

Inventors Okamoto, Mitsuhiro; Takemori, Hiroshi

Agent FB Rice

Pub. Number AU-A-2003257633

PCT Number PCT/JP03/10535

PCT Pub. Number WO2004/018669

Priority 2002/240092 21.08.02 JP; 2003/23295 31.01.03 JP

Filing date 20 August 2003

Wipo publication date 11 March 2004

A61P 003/06 Drugs for disorders of the metabolism

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 009/12 Drugs for disorders of the cardiovascular system

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 001/48 Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C07K 016/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 025/28 Drugs for disorders of the nervous system

A61P 019/06 Drugs for skeletal disorders

A61P 003/04 Drugs for disorders of the metabolism

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 038/45 Medicinal preparations containing peptides

A61K 035/76 Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

C12N 009/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 003/10 Drugs for disorders of the metabolism

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology